New York, NY (PRWEB) March 25, 2013
A recent study* says that diabetes drug Byetta, manufactured by Amylin Pharmaceutical in conjunction with Eli Lilly and Company, could cause damage to the pancreas—even cancer. The Rottenstein Law Group, which is accepting clients in Byetta lawsuits, maintains a Byetta Legal Information Center on its website designed to provide more information on Byetta side effects and lawsuits.
The UCLA study showed increased evidence of pre-cancerous cellular changes associated with Type 2 diabetes treatments, according to Bloomberg. The increase in changes topped 40 percent. In 2007, two years after Byetta went to market, the U.S. Food and Drug Administration said it had received many reports of pancreatitis from Byetta users, the article said. The FDA recently issued a report** indicating it was evaluating the Byetta side effects claims of unpublished research studies.
Rochelle Rottenstein, principal of the Rottenstein Law Group, said that the growing body of evidence*** of Byetta’s alleged pancreatic side effects means that patients should be vigilant about their rights.
“Patients trust drug companies to produce helpful—not potentially harmful—medications,” Rottenstein said. “It is important that patients understand that if they believe they have been harmed there are advocates available to help them navigate the system.”
The Rottenstein Law Group encourages those who believe Byetta injured them to visit its website and contact the firm today.
About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices. (Attorney advertising. Prior results do not guarantee a similar outcome.)
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com